Presented by: Dr. Kevin M. McNabb, PhD, MT
Bloodstream infections leading to sepsis are among the top 10 causes of mortality in the United States. It is commonly recognized that rapid identification and therapy can have a tremendous impact on patient recovery and hospital length of stay.
Data collected over a five year period will be reviewed to demonstrate the impact of migrating from traditional microbiology methods to a rapid molecular diagnostic test, and the drivers behind the adoption of the ePlex® Blood Culture Identification Panels.
Register for this event to learn more about the impact of rapid molecular diagnostic testing for bloodstream infections
The views, opinions, and information expressed in the webinars posted on this website are solely those of the presenters and may not reflect the views or opinions of GenMark Diagnostics, Inc., its subsidiaries or affiliates ("GenMark"). GenMark takes no responsibility for, and makes no representations or warranties whatsoever, express or implied, with respect to the webinars or any information, content or materials presented therein.